BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3088432)

  • 1. [Isolation and characteristics of urokinase-type plasminogen activator from a culture of human embryo lung fibroblasts].
    Shevelev AIa; Barshevskaia TN; Belogurov AA; Kratasiuk GA; Goriunova LE
    Mol Biol (Mosk); 1986; 20(3):778-88. PubMed ID: 3088432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.
    Nulkar MW; Pawse AR
    Indian J Biochem Biophys; 1991 Feb; 28(1):46-51. PubMed ID: 1905268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinase.
    Wojta J; Kirchheimer JC; Turcu L; Christ G; Binder BR
    Thromb Haemost; 1986 Jun; 55(3):347-51. PubMed ID: 3092391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
    Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
    Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells.
    Corti A; Nolli ML; Soffientini A; Cassani G
    Thromb Haemost; 1986 Oct; 56(2):219-24. PubMed ID: 3101222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.
    Booyse FM; Osikowicz G; Feder S; Scheinbuks J
    J Biol Chem; 1984 Jun; 259(11):7198-205. PubMed ID: 6539333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of urokinase from integrated mammalian cell culture cryogel bioreactor and purification of the enzyme using p-aminobenzamidine affinity chromatography.
    Bansal V; Roychoudhury PK; Mattiasson B; Kumar A
    J Mol Recognit; 2006; 19(4):332-9. PubMed ID: 16761300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.
    Stump DC; Lijnen HR; Collen D
    J Biol Chem; 1986 Jan; 261(3):1274-8. PubMed ID: 3080423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular species of plasminogen activators secreted by normal and neoplastic human cells.
    Wilson EL; Becker ML; Hoal EG; Dowdle EB
    Cancer Res; 1980 Mar; 40(3):933-8. PubMed ID: 7193517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical properties of highly purified kidney cultured plasminogen activator (single chain urokinase).
    Sumi H; Kosugi T; Matsuo O; Mihara H
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):119-28. PubMed ID: 7051725
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial purification and characterization of native plasminogen activators from bovine milk.
    Deharveng G; Nielsen SS
    J Dairy Sci; 1991 Jul; 74(7):2060-72. PubMed ID: 1894805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supermacroporous cryogel matrix for integrated protein isolation. Immobilized metal affinity chromatographic purification of urokinase from cell culture broth of a human kidney cell line.
    Kumar A; Bansal V; Andersson J; Roychoudhury PK; Mattiasson B
    J Chromatogr A; 2006 Jan; 1103(1):35-42. PubMed ID: 16368104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
    Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid isolation of high molecular weight urokinase from native human urine.
    Huber K; Kirchheimer J; Binder BR
    Thromb Haemost; 1982 Jun; 47(3):197-202. PubMed ID: 7051408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of subpopulations of human urinary plasminogen activators.
    Hart DA; Kramer R; Cieplak W
    Thromb Haemost; 1984 Apr; 51(2):212-6. PubMed ID: 6539958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human synovial fibroblasts produce urokinase-type plasminogen activator.
    Medcalf RL; Hamilton JA
    Arthritis Rheum; 1986 Nov; 29(11):1397-401. PubMed ID: 3096341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture.
    Bykowska K; Rijken DC; Collen D
    Thromb Haemost; 1981 Oct; 46(3):642-4. PubMed ID: 7198301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
    Rijken DC; Wijngaards G; Welbergen J
    J Lab Clin Med; 1981 Apr; 97(4):477-86. PubMed ID: 6782183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.